Last 12 months
Inside the activity.
9 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2020 Filed Nov 9, 2020 18:01 UTC |
JOHNSON LORIN KDirector
|
OtherCommon Shares | 4,262 | $4.00 | $17,048.00 |
DisclosureSEC source: 0001654954-20-012045 · section16.xml · nonDerivative · entry 1 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,786 Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 20:39 UTC |
Brooks Michael JPresident
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 914 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-012001 · section16.xml · derivative · entry 2 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 914 shares Expires 2020-11-08 Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 20:39 UTC |
Brooks Michael JPresident
|
OtherCommon Shares | 914 | $4.00 | $3,656.00 |
DisclosureSEC source: 0001654954-20-012001 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,241 Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 17:54 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 609 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011986 · section16.xml · derivative · entry 2 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Shares · 609 shares Expires 2020-11-08 Read SEC document |
| November 06, 2020 Filed Nov 9, 2020 17:54 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
OtherCommon Shares | 609 | $4.00 | $2,436.00 |
DisclosureSEC source: 0001654954-20-011986 · section16.xml · nonDerivative · entry 1 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,827 Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 17:39 UTC |
Pay Paul WilliamDirector
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 1,218 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-012096 · section16.xml · derivative · entry 2 Pay Paul William · CIK 0001778480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,218 shares Expires 2020-11-08 Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 17:39 UTC |
Pay Paul WilliamDirector
|
OtherCommon Shares | 1,218 | $4.00 | $4,872.00 |
DisclosureSEC source: 0001654954-20-012096 · section16.xml · nonDerivative · entry 1 Pay Paul William · CIK 0001778480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,654 Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 10:00 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
OtherCommon share warrants (Right to buy) · Derivative | 4,628 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011925 · section16.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 0 Underlying: Common shares · 4,628 shares Expires 2020-11-08 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 10:00 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
OtherCommon Shares | 4,628 | $4.00 | $18,512.00 |
DisclosureSEC source: 0001654954-20-011925 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,128,652 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 15:04 UTC |
Sistilli CarloDirector
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 1,218 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011927 · section16.xml · derivative · entry 2 Sistilli Carlo · CIK 0001777988 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common shares · 1,218 shares Expires 2020-11-08 F1 · ownership.nature: York-Cav Enterprises, Inc. is partially owned by the reporting party. Mr. Sistilli disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 15:04 UTC |
Sistilli CarloDirector
|
OtherCommon shares | 1,218 | $4.00 | $4,872.00 |
DisclosureSEC source: 0001654954-20-011927 · section16.xml · nonDerivative · entry 1 Sistilli Carlo · CIK 0001777988 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by York-Cav Enterprises, Inc. Disclosed balance after: 3,654 F1 · ownership.nature: York-Cav Enterprises, Inc. is partially owned by the reporting party. Mr. Sistilli disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 18:18 UTC |
van der Velden PeterDirector · 10% owner
Lumira Capital Investment Management Inc.Director · 10% owner
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 5,952 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011786 · section16.xml · derivative · entry 4 van der Velden Peter · CIK 0001778046 · Director · 10% owner Lumira Capital Investment Management Inc. · CIK 0001702636 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Lumira Capital II (International), L.P. Disclosed balance after: 0 Underlying: Common Shares · 5,952 shares Expires 2020-11-08 F1 · ownership.nature: This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 18:18 UTC |
van der Velden PeterDirector · 10% owner
Lumira Capital Investment Management Inc.Director · 10% owner
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 64,362 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011786 · section16.xml · derivative · entry 3 van der Velden Peter · CIK 0001778046 · Director · 10% owner Lumira Capital Investment Management Inc. · CIK 0001702636 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Lumira Capital II, L.P. Disclosed balance after: 0 Underlying: Common Shares · 64,362 shares Expires 2020-11-08 F1 · ownership.nature: This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 18:18 UTC |
van der Velden PeterDirector · 10% owner
Lumira Capital Investment Management Inc.Director · 10% owner
|
OtherCommon Shares | 5,952 | $4.00 | $23,808.00 |
DisclosureSEC source: 0001654954-20-011786 · section16.xml · nonDerivative · entry 2 van der Velden Peter · CIK 0001778046 · Director · 10% owner Lumira Capital Investment Management Inc. · CIK 0001702636 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Lumira Capital II (International), L.P. Disclosed balance after: 175,454 F1 · ownership.nature: This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 18:18 UTC |
van der Velden PeterDirector · 10% owner
Lumira Capital Investment Management Inc.Director · 10% owner
|
OtherCommon Shares | 64,362 | $4.00 | $257,448.00 |
DisclosureSEC source: 0001654954-20-011786 · section16.xml · nonDerivative · entry 1 van der Velden Peter · CIK 0001778046 · Director · 10% owner Lumira Capital Investment Management Inc. · CIK 0001702636 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Lumira Capital II, L.P. Disclosed balance after: 1,897,428 F1 · ownership.nature: This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 15:50 UTC |
JOHNSON LORIN KDirector
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011139 · section16.xml · derivative · entry 1 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common shares · 20,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:57 UTC |
Sistilli CarloDirector
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011152 · section16.xml · derivative · entry 1 Sistilli Carlo · CIK 0001777988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common shares · 20,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:51 UTC |
MacDonald Sean ArthurDirector
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011141 · section16.xml · derivative · entry 1 MacDonald Sean Arthur · CIK 0001778981 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common shares · 20,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:57 UTC |
Brooks Michael JPresident
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011151 · section16.xml · derivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common shares · 50,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:57 UTC |
OAKES FRANK R.Director
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011150 · section16.xml · derivative · entry 1 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common shares · 20,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:57 UTC |
Pay Paul WilliamDirector
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011149 · section16.xml · derivative · entry 1 Pay Paul William · CIK 0001778480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common shares · 20,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:54 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011144 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common shares · 60,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:51 UTC |
van der Velden PeterDirector · 10% owner
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011142 · section16.xml · derivative · entry 1 van der Velden Peter · CIK 0001778046 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common shares · 20,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:51 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011140 · section16.xml · derivative · entry 1 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common shares · 50,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| October 06, 2020 Filed Nov 3, 2020 20:33 UTC |
OAKES FRANK R.Director
|
OtherCommon Share Warrants (Right to Buy) · Derivative | 609 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011793 · section16.xml · derivative · entry 3 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Shares · 609 shares Expires 2020-11-08 Read SEC document |
| October 06, 2020 Filed Nov 3, 2020 20:33 UTC |
OAKES FRANK R.Director
|
OtherCommon Shares | 609 | $4.00 | $2,436.00 |
DisclosureSEC source: 0001654954-20-011793 · section16.xml · nonDerivative · entry 1 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,827 Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 09:23 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
OtherCommon Shares | 371,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-20-010224 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by 1968160 Ontario Inc. Disclosed balance after: 371,727 F2 · price: Pardeep Nijhawan acquired 100% of the capital stock of 1968160 Ontario Inc. which holds 371,727 common shares of the issuer, pursuant to the foreign equivalent of a domestic relations order. F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| May 27, 2020 Filed May 29, 2020 13:20 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 1,000 | $3.00 | $3,000.00 |
DisclosureSEC source: 0001654954-20-006075 · section16.xml · nonDerivative · entry 2 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,327 Read SEC document |
| May 27, 2020 Filed May 29, 2020 13:20 UTC |
Brooks Michael JPresident
|
PurchaseCommon Shares | 1,500 | $3.00 | $4,498.50 |
DisclosureSEC source: 0001654954-20-006075 · section16.xml · nonDerivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,327 Read SEC document |
| May 26, 2020 Filed May 28, 2020 12:19 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 3,000 | $2.98 | $8,939.10 |
DisclosureSEC source: 0001654954-20-006029 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation (1) Disclosed balance after: 2,124,024 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 29, 2020 Filed Mar 29, 2021 13:02 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
Pardeep Nijhawan Medicine Professional CorpDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 2,000 | $5.23 | $10,460.00 |
DisclosureSEC source: 0001654954-21-003384 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,312 Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,000 | $1.90 | $1,897.50 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,121,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,000 | $1.83 | $1,828.00 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,120,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,000 | $1.90 | $1,897.80 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 3 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,119,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,000 | $1.86 | $1,859.90 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,118,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Shares | 1,000 | $1.89 | $1,889.90 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,117,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 18:19 UTC |
JOHNSON LORIN KDirector
|
GrantShare Option (Right to Buy) · Derivative | 11,389 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001652 · section16.xml · derivative · entry 1 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,389 Underlying: Common Shares · 11,389 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:19 UTC |
MacDonald Sean ArthurDirector
|
GrantShare Option (Right to Buy) · Derivative | 11,389 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001651 · section16.xml · derivative · entry 1 MacDonald Sean Arthur · CIK 0001778981 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,389 Underlying: Common Shares · 11,389 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:08 UTC |
Sistilli CarloDirector
|
GrantShare Option (Right to Buy) · Derivative | 11,389 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001647 · section16.xml · derivative · entry 1 Sistilli Carlo · CIK 0001777988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,389 Underlying: Common Shares · 11,389 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:19 UTC |
Brooks Michael JPresident
|
GrantShare Option (Right to Buy) · Derivative | 68,988 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001654 · section16.xml · derivative · entry 1 Brooks Michael J · CIK 0001779126 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,988 Underlying: Common Shares · 68,988 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:19 UTC |
van der Velden PeterDirector · 10% owner
|
GrantShare Option (Right to Buy) · Derivative | 11,389 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001653 · section16.xml · derivative · entry 1 van der Velden Peter · CIK 0001778046 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,389 Underlying: Common Shares · 11,389 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:19 UTC |
OAKES FRANK R.Director
|
GrantShare Option (Right to Buy) · Derivative | 11,389 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001655 · section16.xml · derivative · entry 1 OAKES FRANK R. · CIK 0001620188 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,389 Underlying: Common Shares · 11,389 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:19 UTC |
NIFFENEGGER KATHIChief Financial Officer
|
GrantShare Option (Right to Buy) · Derivative | 88,699 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001650 · section16.xml · derivative · entry 1 NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,699 Underlying: Common Shares · 88,699 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:19 UTC |
Pay Paul WilliamDirector
|
GrantShare Option (Right to Buy) · Derivative | 11,389 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001654954-20-001649 · section16.xml · derivative · entry 1 Pay Paul William · CIK 0001778480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,389 Underlying: Common Shares · 11,389 shares Expires 2030-02-12 F1 · derivative.exercise_date: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 14:11 UTC |
JOHNSON LORIN KDirector
|
PurchaseCommon Share Warrants (Right to Buy) · Derivative | 4,262 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001654954-20-000267 · section16.xml · derivative · entry 3 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,262 Underlying: Common Shares · 4,262 shares Expires 2020-11-08 F3 · security: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020. F1 · price: The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 14:11 UTC |
JOHNSON LORIN KDirector
|
PurchaseCommon Share Warrants (Right to Buy) · Derivative | 6,393 | Not disclosed Strike: $4.80 | Not disclosed |
DisclosureSEC source: 0001654954-20-000267 · section16.xml · derivative · entry 2 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,393 Underlying: Common Shares · 6,393 shares Expires 2023-07-08 F2 · security: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023. F1 · price: The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 14:11 UTC |
JOHNSON LORIN KDirector
|
PurchaseCommon Shares | 8,524 | $4.11 | $35,033.64 |
DisclosureSEC source: 0001654954-20-000267 · section16.xml · nonDerivative · entry 1 JOHNSON LORIN K · CIK 0001053878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,524 F1 · price: The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
GrantCommon Share Warrants (Right to Buy) · Derivative | 4,628 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 4,628 Underlying: Common Shares · 4,628 shares Expires 2020-11-08 F4 · security: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020. F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
GrantCommon Share Warrants (Right to Buy) · Derivative | 6,942 | Not disclosed Strike: $4.80 | Not disclosed |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · derivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 6,942 Underlying: Common Shares · 6,942 shares Expires 2023-07-08 F3 · security: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023. F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC |
Nijhawan PardeepDirector · Chief Executive Officer · 10% owner
|
GrantCommon Shares | 9,255 | $4.11 | $38,038.05 |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,116,024 F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.